Literature DB >> 21425950

Topical absorption and systemic toxicity.

Fatima Sasha Alikhan1, Howard Maibach.   

Abstract

Dermal absorption of some chemicals and drugs can cause systemic toxicity. We evaluated several case reports from the past decade, which discuss the dermal absorption of a specific chemical and potential local and systemic effects. We focused on herbicide and pesticide exposure along with exposure to cutaneous medication, occupational contact, and cosmeceutical exposure. Although causality cannot be established in most cases, it is critical to be aware of the possible effects of topical absorption that may not be immediately apparent. We recommended further studies on specific chemicals to ascertain causality and determine the highest exposure level with no observed adverse affect level (NOAEL) and the reference dose (RfD). Post-marketing epidemiology data in most geographical areas are markedly limited. A weak link in public health resides in the inadequate reporting and workup of alleged chemically related adverse effects. This arena mandates a re-thinking of how to increase this reporting, and workup, as a backup to our preclinical and clinical studies. Public awareness and funding will be rewarded by increased evidence to backup pre-approval pre-marketing studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21425950     DOI: 10.3109/15569527.2011.560914

Source DB:  PubMed          Journal:  Cutan Ocul Toxicol        ISSN: 1556-9527            Impact factor:   1.820


  4 in total

1.  Critical illness and multi-organ failure following topical application of skin-lightening preparation.

Authors:  J E Rudge; M Raithatha
Journal:  Anaesth Rep       Date:  2019-06-11

Review 2.  Potential health effects associated with dermal exposure to occupational chemicals.

Authors:  Stacey E Anderson; B Jean Meade
Journal:  Environ Health Insights       Date:  2014-12-17

3.  Developmental Neurotoxic Effects of Percutaneous Drug Delivery: Behavior and Neurochemical Studies in C57BL/6 Mice.

Authors:  Huali Wu; Junyi Feng; Wenting Lv; Qiaoling Huang; Mengsi Fu; Minxuan Cai; Qiangqiang He; Jing Shang
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

4.  Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs.

Authors:  Haroon Mohammad; Nader S Abutaleb; Alexandra M Dieterly; L Tiffany Lyle; Mohamed N Seleem
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.